<DOC>
	<DOCNO>NCT01657448</DOCNO>
	<brief_summary>The purpose study evaluate efficacy combination Methenamine + Methylthioninium chloride compare phenazopyridine ( comparator product ) symptomatic relief dysuria .</brief_summary>
	<brief_title>Efficacy Study Methenamine + Methylthioninium Chloride v Phenazopyridine Symptomatic Control Dysuria</brief_title>
	<detailed_description>- Single blind , randomize , prospective study . - Length experience : 03 day 07 day . - 03 visit ( day 1 , 4 7 ) . - Evaluation efficacy safety medication . - Shall assessed adverse event .</detailed_description>
	<mesh_term>Dysuria</mesh_term>
	<mesh_term>Methylene Blue</mesh_term>
	<mesh_term>Methenamine</mesh_term>
	<mesh_term>Methenamine hippurate</mesh_term>
	<criteria>Patients agree participate agree term propose Clinical trial ; Patients age 18 year ethnicity ; Presence dysuria mark great equal 5 measure point categorical scale pretreatment pain symptom ; Patients febrile ( axillary T º : ≥ 38 ° C ) , back pain lumbar ; Patients complicate clinical presentation urinary tract infection ; Patients history allergy intolerance know suspect one ingredient product investigation ; Patients pregnant lactation , childbearing potential making use effective contraception ; Patients present renal disease severe liver disease , accord medical history / laboratory ; Patients present severe systemic disease accord know medical history ; Patients receive antibiotic treatment , anthelmintic within 7 day prior study entry ; Patients unable understand guideline specify protocol attend study visit unable complete log ; Pregnancy risk pregnancy lactate patient ; Any find clinical observation ( history physical examination ) interpret physician investigator risk patient 's participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Symptom Dysuria</keyword>
</DOC>